Author:
Bekoe Samuel O.,Asare-Nkansah Samuel,Opuni Kwabena F. M.
Publisher
Springer International Publishing
Reference128 articles.
1. Buclin T, Thoma Y, Widmer N, et al. The steps to therapeutic drug monitoring: a structured approach illustrated with imatinib. Front Pharmacol. 2020;11:177.
2. Moffat AC, Osselton MD, Widdop B, Watts J. Clarke’s analysis of drugs and poisons. London: Pharmaceutical Press; 2011.
3. Marshall E, Dearborn EH. The relation of the plasma concentration of quinacrine to its antimalarial activity. J Pharmacol Exp Ther. 1946;88(2):142–53.
4. Abrantes JA, Jonsson S, Karlsson MO, Nielsen EI. Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data. Br J Clin Pharmacol. 2019;85(6):1326–36.
5. Bhattaram VA, Booth BP, Ramchandani RP, et al. Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications. AAPS J. 2005;7(3):E503–12.